Long-term Impact of Infection With Novel Coronavirus (COVID-19) (LIINC)

Long-term Impact of Infection With Novel Coronavirus (COVID-19) (LIINC)

Sponsored by the University of California, San Francisco

In LIINC, University of California researchers are trying to understand the changes that happen to a person's body after they have recovered from the virus.

To be eligible for the study, all that is required is that you are over 18 years old, have tested positive for the COVID-19 virus (SARS-CoV-2) from a mouth or nose swab, and are able to attend at least 1 visit at San Francisco General Hospital.


Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. The virus that causes COVID-19 is a novel coronavirus that was first identified during an investigation into an outbreak in Wuhan, China.

How is this study designed?

Study type: Observational Estimated Enrollment: 800 participants Actual Study Start Date: April 21, 2020 Estimated Study Completion Date: December 21, 2024

Who is this study for?

Study Population The investigators will enroll individuals with prior SARS-CoV-2 infection across a wide spectrum of age, race, gender, and disease severity.

Ages Eligible for Study: 18 Years to 100 Years (Adult, Older Adult)

What should I expect?

Enrolled volunteers are seen at San Francisco General Hospital at enrollment, monthly for up to 3 months and then every 4 months for up to 2 years.

Visits include a detailed interview, saliva collection, and a blood draw. Baseline visits take approximately 90 minutes, and follow up visits take approximately 20-40 minutes. No personal identifiers are used for specimen bank samples.

Participate in the LIINC Study

Thank you for your interest in advancing COVID-19 research.

Please fill out this contact form to be connected to a member of the study team. The following information that you enter will only be authorized to be shared with the research team conducting this specific study.

If you have any difficulties or questions, please contact our support specialists at [email protected]

Have a question?

For general questions about COVID-19 clinical trials, please email [email protected] For study specific inquiries, submit the interest form and you’ll be connected to the study team.